DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Olcegepant
Olcegepant
Current and Prospective Pharmacological Targets in Relation to Antimigraine Action
G Protein-Coupled Receptors
1 Advances in Therapeutic Peptides Targeting G Protein-Coupled
A Multicenter, Randomized, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Ubrogepant in Th
CGRP Signaling Via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia
761077Orig1s000
Anti‐Migraine Calcitonin Gene–Related Peptide Receptor
I Regulations
Advice Concerning the Addition of Certain Pharmaceutical Products
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
CLINICAL REVIEW(S) Clinical Review Laura Jawidzik, MD NDA 211765 Ubrogepant/UBRELVY
Stembook 2018.Pdf
CGRP) Receptor Antagonist HTL0022562
CGRP and Headache: a Brief Review
E-Binder March 2020
G Protein‐Coupled Receptors
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
South Dakota Department of Social Services
Top View
Treatment of Migraine Attacks Based on the Interaction with the Trigemino-Cerebrovascular System
CLINICAL REVIEW(S) Clinical Review Laura Jawidzik, MD NDA (B) (4) and 212728 Rimegepant (B) (4)
Pharmaabkommen A1 E
Cover: Xiomara, by Beca Layout: A
CGRP Antagonists for the Treatment of Migraine: Rationale and Clinical Data
Calcitonin Gene Related Peptide (CGRP) Inhibitors
CGRP Receptor Antagonism and Migraine
Customs Tariff - Schedule Xxi - 1
Bioactive Compound Library Plus (96-Well)
And Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
Ubrogepant: a New Era in Migraine Treatment
Anti‐Migraine Calcitonin Gene–Related Peptide Receptor
Product Data Sheet
Neuropeptide Receptors in Pain Circuitries: Useful Targets for CNS Imaging with Non-Peptide Ligands Suitable for PET?
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
WO 2010/024870 Al
Critical Role of Calcitonin Gene-Related Peptide Receptors in Cortical Spreading Depression
Therapeutic Effects and Safety of Olcegepant and Telcagepant for Migraine: a Meta-Analysis
Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models
Small Molecule Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine
Reference: WLI/100 28 March 2007
G Protein-Coupled Receptors
G Protein-Coupled Receptors
CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
Efficacy of Calcitonin Gene-Related Peptide Antagonists in the Treatment of Acute Migraine: a Systematic Review and Meta-Analysis Kristina M
Current Understanding of Meningeal and Cerebral Vascular Function
Articles Efficacy and Tolerability of MK-0974 (Telcagepant), a New Oral Antagonist of Calcitonin Gene-Related Peptide Receptor
A Second Site of Action for the CGRP Antagonist Olcegepant, a Drug for the Acute Treatment of Migraine
Neurovascular Pharmacology of Prospective Antimigraine Drugs Ka
Dmd #20479 1 Trend Analysis of a Database of Intravenous
E-Binder January 2021
Anti-CGRP Monoclonal Antibodies: a Breakthrough in the Treatment of Migraine
Calcitonin Gene Related Peptide (CGRP) Inhibitors
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri